ClinicalTrials.govpublic full text
Brentuximab Vedotin for Newly Diagnosed cHL in Chinese CAYA Based on PET/CT Assessment
classical hodgkin lymphoma, child, adolescent, young adult, metabolic response, survival, treatment, brentuximab vedotin, pet scan, interventional, phase2, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 877824
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.